Sentinel lymph node biopsy in patients with melanoma and breast cancer
- 25 December 2001
- journal article
- review article
- Published by Wiley in Internal Medicine Journal
- Vol. 31 (9) , 547-553
Abstract
Sentinel lymph node biopsy (SNLB) is a new method for staging regional node fields in patients with cancers that have a propensity to metastasise to lymph nodes. The majority of early experience has been obtained in patients with melanoma and breast cancer.The technique requires the close cooperation of nuclear medicine physicians, surgical oncologists and histopathologists to achieve the desired accuracy. It involves: (i) identification of all lymph nodes that directly drain a primary tumour site (the sentinel nodes) by the use of pre‐operative lymphoscintigraphy, (ii) selective excision of these nodes by the surgeon, guided by pre‐operative blue dye injection and a gamma detecting probe intra‐operatively and (iii) careful histological examination of the sentinel nodes by the histopathologist using serial sections and immunohistochemical stains.If the nodes are normal it can be inferred with a high degree of accuracy that all nodes in the node field are normal. This means that radical dissections of draining node fields can be avoided in patients with normal lymph nodes.A further advantage of lyamphatic mapping is that drainage to sentinel nodes in unusual locations is identified, leading to more accurate nodal staging than could be achieved with routine dissection of the closest node field. (Intern Med J 2001; 31: 547–553)Keywords
This publication has 24 references indexed in Scilit:
- A Response to Lee M. Ellis?s Editorial: A Perspective on Sentinel Lymph Node Biopsy in Colorectal Cancer: The Race Between Surgical Technology and Molecular OncologyAnnals of Surgical Oncology, 2001
- Reliability of sentinel lymph node biopsy for staging melanomaBritish Journal of Surgery, 2000
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- Guidelines for Sentinel Node Biopsy and Lymphatic Mapping of Patients With Breast CancerAnnals of Surgery, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Intraoperative Radiolymphoscintigraphy Improves Sentinel Lymph Node Identification for Patients with MelanomaAnnals of Surgery, 1996
- Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodesMelanoma Research, 1995
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992